483 Roundup: Seven Firms Rapped for Complaint Handling, Other Issues

By Sam | January 13, 2020

The FDA has issued Form 483 inspection reports to seven drug companies for a variety of GMP and other lapses, including problems with data integrity, complaint handling and visual examinations of finished drug products.
Source: Drug GMP Report

Posted in Drug GMP Report